sumatriptan has been researched along with Benign Intracranial Hypertension in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathew, NT | 1 |
Ravishankar, K | 1 |
Sanin, LC | 1 |
Nilsson, F | 1 |
Nilsson, T | 1 |
Edvinsson, L | 1 |
Rosén, I | 1 |
Björkman, S | 1 |
Messeter, K | 1 |
Nordström, CH | 1 |
2 other studies available for sumatriptan and Benign Intracranial Hypertension
Article | Year |
---|---|
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie | 1996 |
Sumatriptan-induced cerebral vasoconstriction as treatment of experimental intracranial hypertension.
Topics: Animals; Cerebral Arteries; Cerebral Veins; Cerebrovascular Circulation; In Vitro Techniques; Pseudo | 1996 |